ExploreWatchlistsPricing
  1. JP-listed companies
  2. Shionogi & Co.,Ltd.
  3. Financials
  4. Operating income

Shionogi & Co.,Ltd. (4507)

Market cap
¥2.86T
P/E ratio
14.6x
Develops, manufactures and sells prescription pharmaceuticals globally, specializing in infectious diseases and central nervous system disorders.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndOperating income (Million JPY)YoY (%)
Mar 31, 2025156,603+2.15%
Mar 31, 2024153,310+2.89%
Mar 31, 2023149,003+35.07%
Mar 31, 2022110,312-6.07%
Mar 31, 2021117,438-10.10%
Mar 31, 2020130,628-5.71%
Mar 31, 2019138,537+20.24%
Mar 31, 2018115,219+6.51%
Mar 31, 2017108,178+18.35%
Mar 31, 201691,406+81.49%
Mar 31, 201550,365

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat